Buphenine: Difference between revisions
Appearance
Content deleted Content added
merge from nylidrin |
ref |
||
Line 25: | Line 25: | ||
}} |
}} |
||
'''Buphenine''' (or '''nylidrin''') is a [[sympathomimetic]] and [[beta-adrenergic agonist]]. |
'''Buphenine''' (or '''nylidrin''') is a [[sympathomimetic]]<ref name="pmid2857689">{{cite journal |author=Mittag TW, Tormay A, Messenger M, Podos SM |title=Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin |journal=Invest. Ophthalmol. Vis. Sci. |volume=26 |issue=2 |pages=163–9 |year=1985 |month=February |pmid=2857689 |doi= |url=http://www.iovs.org/cgi/pmidlookup?view=long&pmid=2857689}}</ref> and [[beta-adrenergic agonist]]. |
||
==References== |
|||
{{reflist}} |
|||
{{pharma-stub}} |
{{pharma-stub}} |
Revision as of 18:29, 22 July 2008
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.531 |
Chemical and physical data | |
Formula | C19H25NO2 |
Molar mass | 299.41 g/mol g·mol−1 |
Buphenine (or nylidrin) is a sympathomimetic[1] and beta-adrenergic agonist.
References
- ^ Mittag TW, Tormay A, Messenger M, Podos SM (1985). "Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin". Invest. Ophthalmol. Vis. Sci. 26 (2): 163–9. PMID 2857689.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link)